Henry Schein reports record-breaking results for 2015

Henry Schein has achieved a record-breaking financial performance for 2015, with net sales up by 2.5 percent year-on-year to reach a total of $10.6 billion (7.34 billion pounds).

This reflected an 8.4 percent rise in local currency sales terms, offsetting a 5.9 percent decline related to foreign currency exchange. In local currencies, internally generated sales increased five percent and acquisition growth was 3.4 percent.

A strong fourth-quarter performance was cited as a key contributor to the record results, with sales up by 5.5 percent to a total of $2.9 billion. Positive momentum was seen in North America and many key international markets, including the UK.

The investments in companies such as Dental Trey, Dental Cremer, Jorgen Kruuse and RxWorks have all been cited as important steps that will help to drive future growth.

Stanley Bergman, chairman of the board and chief executive officer of Henry Schein, said: "We are delighted to report that sales growth during the fourth quarter was particularly strong, and we believe we gained market share on an overall basis during the quarter both in North America and internationally."

For 2016, the company expects adjusted diluted earnings per share to be between $6.55 and $6.65, representing growth of ten to 12 percent compared to 2015.